ExploreWatchlistsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Return on Assets

AbbVie Inc. (ABBV)

Market cap
$401.8B
P/E ratio
96.3x
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 20253.2-0.94%
Dec 31, 20243.2-10.67%
Dec 31, 20233.6-57.11%
Dec 31, 20228.3+6.82%
Dec 31, 20217.8+101.30%
Dec 31, 20203.9-63.65%
Dec 31, 201910.6+21.51%
Dec 31, 20188.7+12.63%
Dec 31, 20177.8-22.32%
Dec 31, 201610

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat